Sections

Home | Drugs Approvals and Trials

Drugs Approvals and Trials

New method improves stability, extends shelf life of protein drugs

Jessica Sieff Gaining access to important biopharmaceuticals needed to treat illnesses and autoimmune diseases is one of the biggest obstacles developing countries face. ...

Simpler website navigation for regulatory information on human medicines

New navigation to help users find information more easily ...

Glycocluster design could lead to targeted drug delivery

A team led by researchers at the RIKEN Biofunctional Synthetic Chemistry Laboratory in Japan has developed a way to engineer glycan complexes—clusters of sugar chains attached to proteins or lipids—in a way that allows the molecules to be transported preferentially to specific organs of the body, depending on the sugar chains contained in the cluster. According to Katsunori Tanaka, the leader of the team, this work, which was published in Advanced Science, could lead to the development of glycocluster-based diagnostic tools with better selectivity and precision than current tracers based on peptides and antibodies. ... Full story

Clinical data for two more medicines now available online

EMA provides public access to clinical reports ... Full story

Clinical Trial Data Sharing Off to a Slow Start

A Rutgers paper in The New England Journal of Medicine explores why long-awaited access to drug trial data is underused ... Full story

Promising new lupus drug being tested at Temple

The drug—anifrolumab—was shown to reduce symptoms in patients in early phases of clinical research. ... Full story

Major advance in designer drug development

In a world-first, researchers from The University of Queensland and University of Washington (UW) have produced tailor-made peptides – an advance expected to help improve drug design and environmentally-friendly pesticides. ... Full story

Atomic-scale MRI holds promise for new drug discovery

Researchers at the University of Melbourne have developed a way to radically miniaturise a Magnetic Resonance Imaging (MRI) machine using atomic-scale quantum computer technology. ... Full story

Single-Arm Trials Improve Early Access to Rare Cancer Drugs

LUGANO-COPENHAGEN – Although randomised clinical trials (RCTs) remain the gold standard for evaluating the benefit/risk of cancer drugs, single-arm trials (SATs) can provide invaluable opportunities ... Full story

New research to offer blueprint for oral drug delivery

Scientists are working to develop a blueprint for a new generation of nanomedicines that could soon make it possible for patients to take medicines such as insulin orally rather than via injections. ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 580 | displaying: 1 - 10